These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 11042674)
1. Activation of protein kinase C relays distinct signaling pathways in the same cell type: differentiation and caspase-mediated apoptosis. Meinhardt G; Roth J; Hass R Cell Death Differ; 2000 Sep; 7(9):795-803. PubMed ID: 11042674 [TBL] [Abstract][Full Text] [Related]
2. Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways. Meinhardt G; Roth J; Totok G Eur J Cell Biol; 2000 Nov; 79(11):824-33. PubMed ID: 11139146 [TBL] [Abstract][Full Text] [Related]
3. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells. Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354 [TBL] [Abstract][Full Text] [Related]
4. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135 [TBL] [Abstract][Full Text] [Related]
5. PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells. Matsumoto E; Hatanaka M; Bohgaki M; Maeda S Kobe J Med Sci; 2006; 52(6):181-94. PubMed ID: 17329956 [TBL] [Abstract][Full Text] [Related]
6. Distinct MAPK signaling pathways, p21 up-regulation and caspase-mediated p21 cleavage establishes the fate of U937 cells exposed to 3-hydrogenkwadaphnin: differentiation versus apoptosis. Moosavi MA; Yazdanparast R Toxicol Appl Pharmacol; 2008 Jul; 230(1):86-96. PubMed ID: 18394670 [TBL] [Abstract][Full Text] [Related]
7. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis. Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069 [TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells. De Saint Jean M; Brignole F; Feldmann G; Goguel A; Baudouin C Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2199-212. PubMed ID: 10476784 [TBL] [Abstract][Full Text] [Related]
9. Requirement for caspase activation in monocytic differentiation of myeloid leukemia cells. Pandey P; Nakazawa A; Ito Y; Datta R; Kharbanda S; Kufe D Oncogene; 2000 Aug; 19(34):3941-7. PubMed ID: 10951587 [TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells. Sordet O; Bettaieb A; Bruey JM; Eymin B; Droin N; Ivarsson M; Garrido C; Solary E Cell Death Differ; 1999 Apr; 6(4):351-61. PubMed ID: 10381626 [TBL] [Abstract][Full Text] [Related]
11. 12-o-Tetradecanoylphorbol 13-acetate prevents baicalein-induced apoptosis via activation of protein kinase C and JNKs in human leukemia cells. Chow JM; Shen SC; Wu CY; Chen YC Apoptosis; 2006 Nov; 11(11):1999-2011. PubMed ID: 17013757 [TBL] [Abstract][Full Text] [Related]
12. Inactive caspase 3 activates Akt in human leukemia cells susceptible or resistant to apoptosis induced by phorbol ester. Hah JO; Lee KA; Choi YJ; Kim WD; Park JW; Kwon TK Int J Oncol; 2003 May; 22(5):1111-6. PubMed ID: 12684678 [TBL] [Abstract][Full Text] [Related]
13. Signaling defect in the activation of caspase-3 and PKCdelta in human TUR leukemia cells is associated with resistance to apoptosis. Meinhardt G; Roth J; Totok G; Auner H; Emmerich B; Hass R Exp Cell Res; 1999 Mar; 247(2):534-42. PubMed ID: 10066381 [TBL] [Abstract][Full Text] [Related]
14. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells. Wu SJ; Ng LT; Lin CC Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126 [TBL] [Abstract][Full Text] [Related]
15. Phorbol ester-resistant monoblastoid leukemia cells with a functional mitogen-activated protein kinase cascade but without responsive protein tyrosine phosphatases. Seimiya H; Sawabe T; Toho M; Tsuruo T Oncogene; 1995 Nov; 11(10):2047-54. PubMed ID: 7478524 [TBL] [Abstract][Full Text] [Related]
16. Differentiation and retrodifferentiation of human myeloid leukemia cells is associated with reversible induction of cell cycle-regulatory genes. Hass R; Gunji H; Datta R; Kharbanda S; Hartmann A; Weichselbaum R; Kufe D Cancer Res; 1992 Mar; 52(6):1445-50. PubMed ID: 1531783 [TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. Rosato RR; Almenara JA; Grant S Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953 [TBL] [Abstract][Full Text] [Related]
18. Annexin V inhibits the 12-O-tetradecanoylphorbol-13-acetate-induced activation of Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of Shc in MCF-7 cells. Sato H; Ogata H; De Luca LM Oncogene; 2000 Jun; 19(25):2904-12. PubMed ID: 10871841 [TBL] [Abstract][Full Text] [Related]
19. Mitochondrial targeting of JNK/SAPK in the phorbol ester response of myeloid leukemia cells. Ito Y; Mishra NC; Yoshida K; Kharbanda S; Saxena S; Kufe D Cell Death Differ; 2001 Aug; 8(8):794-800. PubMed ID: 11526432 [TBL] [Abstract][Full Text] [Related]
20. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis. Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]